Cargando…
Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel
Introduction: Myelin oligodendrocyte glycoprotein (MOG) antibody associated disorders (MOGAD) have been recognized over the past 10 years as distinct inflammatory, demyelinating diseases of the central nervous system (CNS). Antibodies against MOG are found mostly in patients with optic neuritis (ON)...
Autores principales: | Brill, Livnat, Ganelin-Cohen, Esther, Dabby, Ron, Rabinowicz, Shira, Zohar-Dayan, Efrat, Rein, Netaniel, Aloni, Eyal, Karmon, Yuval, Vaknin-Dembinsky, Adi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874097/ https://www.ncbi.nlm.nih.gov/pubmed/33584514 http://dx.doi.org/10.3389/fneur.2020.612304 |
Ejemplares similares
-
Description of 3 patients with myasthenia gravis and COVID-19
por: Rein, Netaniel, et al.
Publicado: (2020) -
Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis
por: Lavon, Iris, et al.
Publicado: (2019) -
Clinical outcomes of COVID-19 in patients with multiple sclerosis treated with ocrelizumab in the pre- and post-SARS-CoV-2 vaccination periods: Insights from Israel
por: Weberpals, Janick, et al.
Publicado: (2022) -
NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness
por: Mizrachi, Tehila, et al.
Publicado: (2018) -
Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis
por: Brill, Livnat, et al.
Publicado: (2022)